• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新冠病毒疫苗接种策略对维多利亚州非季节性疫情波模式下感染和住院情况的影响:一项建模研究。

Evaluating the impact of COVID-19 vaccination strategies on infections and hospitalisations in Victoria with non-seasonal epidemic wave patterns: a modelling study.

作者信息

McAndrew Fenella, Abeysuriya Romesh, Scott Nick

机构信息

Burnet Institute, Melbourne, VIC.

Monash University, Melbourne, VIC.

出版信息

Med J Aust. 2025 Jun 16;222(11):558-566. doi: 10.5694/mja2.52677. Epub 2025 Jun 1.

DOI:10.5694/mja2.52677
PMID:40450593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12167612/
Abstract

OBJECTIVES

To assess the impact of different coronavirus disease 2019 (COVID-19) vaccination strategies on infections and hospitalisations in the context of non-seasonal epidemic waves.

STUDY DESIGN

Dynamic compartmental model-based analysis.

SETTING

Victoria (Australia).

INTERVENTION

Alternative COVID-19 vaccination strategies: baseline (low population coverage - 18-64 years, 7%; 65 years or older, 44% - vaccinations distributed evenly across the year); high coverage for all age groups, with vaccinations spread across year; increased coverage for people aged 65 years or older; annual vaccination campaigns that achieve coverage equivalent to that of influenza vaccinations (18-64 years, 25%; 65 years or older, 59%), commencing in March (same time as influenza vaccination campaign), August, or December; no further COVID-19 vaccinations for people under 65 years of age; no further COVID-19 vaccinations for anyone. Vaccination scenarios used different assumptions about COVID-19 epidemic wave periodicity, and peak infections magnitude and month.

MAIN OUTCOME MEASURES

Mean incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and COVID-19-related hospitalisations over a ten-year projection period.

RESULTS

The low baseline population level of recent COVID-19 vaccination means that any increase in coverage could reduce infection and hospitalisation incidence. Increasing COVID-19 vaccination coverage to match that of influenza vaccination with an annual vaccination campaign reduced the mean incidence of infections by 1-13% and that of hospitalisations by 3-14%, depending on the timing of vaccination campaigns with respect to the epidemic infections peak and assumptions about epidemic wave characteristics. Increasing coverage for people aged 65 years or older reduced hospitalisation incidence by 9-26%, but required twice as many vaccine doses as the annual campaign strategies.

CONCLUSIONS

Annual COVID-19 vaccination campaigns at the same time as those for influenza vaccination could reduce the number of COVID-19-related hospitalisations, with lower logistical requirements than alternative approaches.

摘要

目的

评估在非季节性疫情浪潮背景下,不同的2019冠状病毒病(COVID-19)疫苗接种策略对感染和住院情况的影响。

研究设计

基于动态 compartmental 模型的分析。

研究地点

维多利亚州(澳大利亚)。

干预措施

替代性COVID-19疫苗接种策略:基线(低人群覆盖率——18至64岁,7%;65岁及以上,44%——全年均匀分配疫苗接种);所有年龄组高覆盖率,疫苗接种全年分散进行;65岁及以上人群覆盖率增加;年度疫苗接种活动,实现与流感疫苗接种相同的覆盖率(18至64岁,25%;65岁及以上,59%),分别于3月(与流感疫苗接种活动同时)、8月或12月开始;65岁以下人群不再接种COVID-19疫苗;任何人都不再接种COVID-19疫苗。疫苗接种方案对COVID-19疫情浪潮的周期性、感染峰值大小和月份采用了不同假设。

主要观察指标

在十年预测期内严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的平均发病率以及与COVID-19相关的住院情况。

结果

近期COVID-19疫苗接种的低基线人群水平意味着覆盖率的任何提高都可以降低感染和住院发病率。通过年度疫苗接种活动将COVID-19疫苗接种覆盖率提高到与流感疫苗接种相同的水平,可使感染的平均发病率降低1%至13%,住院平均发病率降低3%至14%,这取决于疫苗接种活动相对于疫情感染峰值的时间以及对疫情浪潮特征的假设。提高65岁及以上人群的覆盖率可使住院发病率降低9%至26%,但所需疫苗剂量是年度活动策略的两倍。

结论

与流感疫苗接种同时进行年度COVID-19疫苗接种活动可减少与COVID-19相关的住院人数,且后勤需求低于其他替代方法。

相似文献

1
Evaluating the impact of COVID-19 vaccination strategies on infections and hospitalisations in Victoria with non-seasonal epidemic wave patterns: a modelling study.评估新冠病毒疫苗接种策略对维多利亚州非季节性疫情波模式下感染和住院情况的影响:一项建模研究。
Med J Aust. 2025 Jun 16;222(11):558-566. doi: 10.5694/mja2.52677. Epub 2025 Jun 1.
2
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后,mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果:一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
3
The impact of re-opening the international border on COVID-19 hospitalisations in Australia: a modelling study.重新开放国际边境对澳大利亚 COVID-19 住院人数的影响:一项建模研究。
Med J Aust. 2022 Jan 17;216(1):39-42. doi: 10.5694/mja2.51291. Epub 2021 Oct 11.
4
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
5
First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death.首剂 SARS-CoV-2 疫苗加强针和流感疫苗接种:COVID-19 住院和死亡的风险评估。
Epidemiol Prev. 2022 Sep-Dec;46(5-6):324-332. doi: 10.19191/EP22.5-6.070.
6
BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.BNT162b2 和 ChAdOx1 nCoV-19 疫苗接种、苏格兰在 Delta 时代 SARS-CoV-2 感染和 COVID-19 住院的发生率。
J Glob Health. 2022 Mar 26;12:05008. doi: 10.7189/jogh.12.05008. eCollection 2022.
7
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.2022 年至 2023 年秋冬期间,老年欧洲人群中的 COVID-19 疫苗有效性。
JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258.
8
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
9
Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023-March 2024).2023/24年秋冬新冠病毒季节性加强针接种活动对预防意大利严重新冠病例的影响(2023年10月至2024年3月)
Vaccine. 2024 Dec 2;42(26):126375. doi: 10.1016/j.vaccine.2024.126375. Epub 2024 Sep 18.
10
Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.模型估计的美国小学相关 SARS-CoV-2 传播、缓解干预措施与疫苗接种率之间的关联,按当地发病水平分类。
JAMA Netw Open. 2022 Feb 1;5(2):e2147827. doi: 10.1001/jamanetworkopen.2021.47827.

本文引用的文献

1
Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections.对患者和医护人员的 N95 口罩进行入院筛查检测,可降低 COVID-19 医院获得性感染的成本效益。
J Hosp Infect. 2024 Oct;152:81-92. doi: 10.1016/j.jhin.2024.06.015. Epub 2024 Jul 15.
2
Factors associated with vaccination intention and uptake over time in a sample of older Australians.随着时间的推移,在澳大利亚老年人样本中与疫苗接种意愿和接种率相关的因素。
Vaccine. 2024 Jun 11;42(16):3601-3606. doi: 10.1016/j.vaccine.2024.04.069. Epub 2024 May 3.
3
Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies.季节性流感疫苗接种的真实世界效果及其作为效应修饰因素的年龄:一项基于病例对照研究的系统评价、荟萃分析和荟萃回归研究。
Vaccine. 2024 Mar 19;42(8):1883-1891. doi: 10.1016/j.vaccine.2024.02.059. Epub 2024 Feb 28.
4
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比,既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用:系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.
5
The Psychology of COVID-19 Booster Hesitancy, Acceptance and Resistance in Australia.澳大利亚民众对新冠病毒加强针的犹豫、接受与抵触心理
Vaccines (Basel). 2023 Apr 27;11(5):907. doi: 10.3390/vaccines11050907.
6
COVID-19 epidemic modelling for policy decision support in Victoria, Australia 2020-2021.2020-2021 年澳大利亚维多利亚州 COVID-19 疫情模型对政策决策的支持
BMC Public Health. 2023 May 27;23(1):988. doi: 10.1186/s12889-023-15936-w.
7
Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis.评估 SARS-CoV-2 疫苗诱导免疫的衰减:系统评价和荟萃分析。
JAMA Netw Open. 2023 May 1;6(5):e2310650. doi: 10.1001/jamanetworkopen.2023.10650.
8
Predicting the efficacy of variant-modified COVID-19 vaccine boosters.预测变异株改良 COVID-19 疫苗加强针的效力。
Nat Med. 2023 Mar;29(3):574-578. doi: 10.1038/s41591-023-02228-4. Epub 2023 Mar 2.
9
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.先前感染 SARS-CoV-2 和混合免疫对奥密克戎变异株和重症疾病的保护效力:系统评价和荟萃回归分析。
Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18.
10
COVID-19 vaccination coverage and vaccine hesitancy among Australians with disability and long-term health conditions.澳大利亚残疾和长期患病人群的 COVID-19 疫苗接种率和疫苗犹豫情况。
Health Promot J Austr. 2023 Oct;34(4):895-902. doi: 10.1002/hpja.691. Epub 2023 Jan 11.